|
WO2020099683A1
|
|
Metabolites for use in ovarian cancer detection and diagnosis
|
|
EP3351938A1
|
|
New biomarkers for assessing ovarian cancer
|
|
US2017016908A1
|
|
Biomarkers for assessing kidney diseases
|
|
AU2015314220A1
|
|
Biomarkers for assessing breast cancer
|
|
BR112016023170A2
|
|
biomarkers for hiv assessment
|
|
AU2015200263A1
|
|
Inflammation and oxidative stress level assay
|
|
EP2917738A1
|
|
Use of quality indicators for checking thawing processes in frozen sample tissues
|
|
WO2011161186A1
|
|
Method for in vitro diagnosing sepsis utilizing biomarker composed of more than two different types of endogenous biomolecules
|
|
WO2011157655A1
|
|
Use of bile acids for prediction of an onset of sepsis
|
|
EP2492690A1
|
|
Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants
|
|
EP2339352A1
|
|
Use of endogenous metabolites for early diagnosing sepsis
|
|
EP2284540A1
|
|
Method of diagnosing organ failure
|
|
EP2270699A1
|
|
Method for normalization in metabolomics analysis methods with endogenous reference metabolites
|
|
SG176655A1
|
|
New biomarkers for assessing kidney diseases
|
|
EP2239675A1
|
|
Method for in vitro diagnosing a complex disease
|
|
EP2036610A2
|
|
Mount for a holder for inserting in a cylindrical opening of a well of a multiwell-, titration- or filtrationplate
|
|
EP2164980A1
|
|
Biomarker and method for determining an oxidative stress level
|
|
AU2008256444A1
|
|
Inflammation and oxidative stress level assay
|
|
ZA200709815B
|
|
Device for quantitative analysis of a metabolite profile
|
|
NZ563431A
|
|
Device for quantitative analysis of a metabolite profile
|
